Becton Dickinson BDX
NYSE BDX
$179.76 +1.71 (+0.96%)
As of: Sep 9, 2026 · 3:59 PM EDT

Becton Dickinson (BDX) Total Current Liabilities (2009 - 2026)

Becton Dickinson's (BDX) quarterly Total Current Liabilities came in at $9.4 billion in Q2 2026, up 15.25% year-over-year from $8.2 billion in Q2 2025, and up 10.54% quarter-over-quarter from $8.5 billion in Q1 2026.

Analysis

Becton Dickinson (BDX) Total Current Liabilities (2009 - 2026) Analysis & Trends

Becton Dickinson (BDX) has reported Total Current Liabilities for 18 consecutive years, with $9.4 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Current Liabilities rose 15.25% year-over-year to $9.4 billion in Q2 2026; TTM through Jun 2026 was $9.4 billion, a 15.25% increase from a year earlier, with the FY2025 full-year figure at $8.3 billion, down 7.18% from the prior year.
  • Total Current Liabilities was $9.4 billion for Q2 2026 at Becton Dickinson, up from $8.5 billion in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $9.4 billion in Q2 2026 and troughed at $6.6 billion in Q2 2024.
  • A 5-year average of $7.7 billion and a median of $7.6 billion in 2022 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities retreated 14.98% in 2023 and surged 34.86% in 2024, its largest moves.
  • Over 5 years, Total Current Liabilities stood at $7.6 billion in 2022, then decreased by 1.11% to $7.5 billion in 2023, then climbed by 1.64% to $7.7 billion in 2024, then climbed by 14.31% to $8.8 billion in 2025, then rose by 7.34% to $9.4 billion in 2026.
  • The last three Total Current Liabilities figures came in at $9.4 billion (Q2 2026), $8.5 billion (Q1 2026), and $8.8 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Becton Dickinson 50.32 Bn 49.46 Bn 2.32 Bn 9.40 Bn
2 Medline 48.11 Bn 52.93 Bn 2.22 Bn 2.71 Bn
3 West Pharmaceutical Services 23.93 Bn 23.49 Bn 329.20 Mn 640.50 Mn
4 Baxter International 13.34 Bn 11.16 Bn 1.03 Bn 3.59 Bn
5 Stevanato Group S.p.A 6.21 Bn 6.11 Bn 100.91 Mn -
6 Acme United 241.34 Mn 236.30 Mn 26.69 Mn 34.81 Mn
7 Rockwell Medical 31.74 Mn 6.94 Mn 3.24 Mn 11.17 Mn
8 Retractable Technologies 21.26 Mn -18.61 Mn 190,852.00 13.37 Mn
9 United Health Products 12.24 Mn 12.21 Mn - 4.19 Mn
10 Cuprina Holdings (Cayman) 8.09 Mn 4.97 Mn - 3.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.40 Bn
Mar 31, 2026 8.51 Bn
Dec 31, 2025 8.76 Bn
Sep 30, 2025 8.31 Bn
Jun 30, 2025 8.16 Bn
Mar 31, 2025 7.69 Bn
Dec 31, 2024 7.66 Bn
Sep 30, 2024 8.96 Bn
Jun 30, 2024 6.61 Bn
Mar 31, 2024 7.33 Bn
Dec 31, 2023 7.54 Bn
Sep 30, 2023 6.64 Bn
Jun 30, 2023 6.88 Bn
Mar 31, 2023 7.30 Bn
Dec 31, 2022 7.63 Bn
Sep 30, 2022 7.81 Bn
Jun 30, 2022 7.08 Bn
Mar 31, 2022 6.66 Bn
Dec 31, 2021 6.74 Bn
Sep 30, 2021 6.63 Bn